Top Markets
#1 Siren Siren +33.90%
#2 Wiki Cat Wiki Cat +25.38%
#3 TRIA TRIA +20.37%
#4 Ribbita by Virtuals Ribbita by Virtuals +17.09%
#5 PulseChain PulseChain +16.92%
#6 Velvet Velvet +15.56%
#7 Bitway Bitway +15.11%
#8 Nockchain Nockchain +14.64%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +14.63%
#10 KUB Coin KUB Coin +14.59%
Coin of the day
Siren Siren
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Smruthi Organics Limited Smruthi Organics Limited

Smruthi Organics Limited

SMRUTHIORG
Kedudukan dalam Saham #30775
Smruthi Organics Ltd. primarily focuses on the production and commercialization... Smruthi Organics Ltd. primarily focuses on the production and commercialization of bulk pharmaceutical ingredients and their chemical intermediates. The company's product range includes a variety of compounds such as amlodipine besilate, amisulpride, carbidopa, ciprofloxacin, diloxanide furoate, fenofibrate, metformin hydrochloride, norfloxacin, pefloxacin, telmisartan, amlodipine base, and phthaloyl amlodipine. This enterprise was established on July 11, 1989, by Purushotham Mallayya Eaga and is based in Solapur, India.
Harga Saham
$1.36
Modal Pasaran
$15.59M
Perubahan (1 hari)
0.57%
Perubahan (1 tahun)
1.48%
Negara
IN
Perdagangan Smruthi Organics Limited (SMRUTHIORG)

Kategori

Healthcare
Pendapatan untuk Smruthi Organics Limited (SMRUTHIORG)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Smruthi Organics Limited, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Smruthi Organics Limited dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT